D'Incà, R
477  results:
Search for persons X
?
1

Golimumab improves health-related quality of life of patien..:

Saibeni, S. ; Bezzio, C. ; Bossa, F....
Digestive and Liver Disease.  56 (2024)  1 - p. 83-91 , 2024
 
?
 
?
 
?
 
?
5

P329 Comparative Assessment of Adalimumab Trough Levels bet..:

Marsilio, I ; Maniero, D ; Lorenzon, G...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S353-S353 , 2021
 
?
6

P295 Comparative Assessment of Infliximab Trough Levels bet..:

Maniero, D ; Lorenzon, G ; Marsilio, I...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S325-S325 , 2021
 
?
 
?
 
?
 
?
10

P468 Switching from adalimumab originator to ABP 501 biosim..:

Barberio, B ; Melatti, P ; Zingone, F...
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S414-S414 , 2020
 
?
11

P668 Real-life comparison of different anti-TNF biologic th..:

Barberio, B ; Zingone, F ; D'Incà, R...
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S548-S549 , 2020
 
?
 
?
 
?
14

P843 Intestinal microbiota changes according to disease act..:

Barberio, B ; Bertazzo, E ; Marinelli, C...
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S651-S652 , 2020
 
?
15

P415 The anti-IL-23/IL-12 agent Ustekinumab is an effective..:

Gubbiotti, A ; Barberio, B ; Zingone, F...
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S379-S379 , 2020
 
1-15